A comprehensive synopsis on cognizance of Regulatory Affairs in different sectors of Pharmacy
A pharmaceutical drug regulatory Affairs is mainly involved in registration process parameters of different pharmaceutical products and new drug application. Regulatory affairs (RA) professionals play vital roles in a pharmaceutical field as, it is related to healthcare products. It provides strategic, operational direction and support for working within regulations to expedite the development of pharmaceutical, biological and medical devices. Also, it is principally concern with safety and efficacy, low risk/high benefit and quality assessment of healthcare drug products throughout the world. Regulatory system of each and every country has different regulatory agencies which govern certification and good manufacturing practices. Regulatory Affairs also has a very specific importance within the formulation and marketing of drug product in pharmaceutical industries. Current abstract reports for the first time and emphasizes on studies concerning awareness and knowledge testing in regulatory affair field by the various pharma professionals. This is completely certified online survey of quiz questionnaire based on important concepts in RA and circulated via google form to different social medias to more than 1000 pharma professionals (Academics, Students, Industrials area). The systematic analysis of received responses reveals awareness and knowledge of the participants about RA in selected pharma professionals. It shows that, participants form industrial area having more knowledge than academics and students. This survey comes out with conclusion that, there is more need to raise RA information sources by the inclusion of this subject in syllabus for academics via various courses to fulfill more RA professional demands in future.
2. Brahmaiah B, Harsha Y et.al., Mary D. Nagabhusanam M. V., Reddy D.N., Reddy V.S, Role of regulatory affairs in a pharmaceutical industry volume, International Journal of Pharmaceutical Research and Bioscience. 2017;6(2): 170-177.
3. Yogeshkumar B. V. Regulatory Affair: Link between company and Government Authority. PharmaTutor. | magazine.pharmatutor.org. 2014; 2(6);9-20.
4. Christian K. S., Torbjo M.et.al. The emergence of regulatory science in pharmaceutical medicine. Switzerland: Springer International Publishing; Pharm Med. 2013;27:345–351.
5. Hasumati R. Historical Overview of Pharmaceutical Industry and Drug Regulatory Affairs. Kurz, Pharmaceut Reg Affairs. 2021; 002:1-11.
6. Keshari R., Jha A. et.al. Role of regulatory affairs in pharmaceutical company: an overview. Global Journal For Research Analysis. 2018;7(1):51-53.
7. Neeti M., Shweta D. Vrinda K. Globalization of Regulatory Affairs in healthcare industry. Asian Journal of Pharmaceutical Clinical Research. 2015; 8(6): 46-49.
8. Andrea G., Ikaela M. S. Drug Review Differences across the United States and the European Union. Pharmaceutical Regulatory Affairs. 2015; 4: e156 (4):1-2.
9. Medicines, medical devices and blood regulation and safety, Marketing authorisations, variations and licensing guidance [Internet]. Gov.uk; 2021 [cited 2021 Sep 21]. Available from:
10. Brahmaiah B., Hanuja G.S., Nagabhushanam M.V., Reddy D.N., Sai B. K. et.al. Current Regulatory Requirements For Registration Of Medicines. Compilation and Submission of Dossier In Australian Therapeutic Goods Administration. 2016;6(6):144-157.
11. Marketing authorization holder (MAH). Support for entry into Japanese markets. CRO Services [Internet]. micjp.co.jp; 2021 [cited 2021 Sep 21]. Available from:
12. Marketing Authorization, Health Canada [Internet]. canada.ca; 2017Apr 11 [cited 2021 Sep 21]. Available from:
13. Goswami R., Kumar B. J., Makvana P., Prajapati V. et. al. A review on drug approval process for US, Europe and India. International Journal of Drug Regulatory Affairs. 2014;2(1):1- 11.
14. Jain A., Pramod K. T.M, Reddy G. R. M., Venkatesh M. P. Regulatory requirements & marketing authorization of generic drugs in singapore & Thailand. International Journal of Drug Regulatory Affairs. 2015;3(1): 62-74.
15. Praneeth P., Regulatory Affairs and its Role in Pharmaceutical Industry, SSRG International Journal of Pharmacy and Biomedical Engineering. 2016;3 (1): 1-2.
16. Reddy GTK, Reddy GNK;Significance of Pharmaceutical Regulatory Bodies - A Review; PharmaTutor; 2017; 5(8); 15-22
17. Desai B. R., Mahaparale S. P et. al. Role and overview of drug regulatory affairs in pharmaceutical industry with implementation of CTD and eCTD. World Journal of Pharmaceutical Research. 2018;7 (7):201-215.
18. Kiranmai B., Swarupa A., Sharma J.V.C., Vanampalli S. et. al. A concise review on pharmaceutical drug regulation. International journal of Research and Analytical Reviews. 2019; 2(9):501-509.
19. Bodla R., Badjatya JK. Harmonization & advancement in pharmaceutical industry. International Journal of Drug Regulatory Affairs. 2017;1(2):7-10.
20. Bandgar P. S., Hingane L. D., Rokade V. G., Review on regulatory affairs in pharmaceutical indusrties. 2020;7(1), 66-73.
21. Sanghi D. K., Tiwle R. et. al. Role of regulatory affairs in a pharmaceutical industry. IJPRR. 2014;4(2):127-131.
22. Bhairav B. A., Jadhav M. S., Saudagar R.B. International journal of universal pharmacy and bio sciences. IJUPBS. 2016;5(3):36-45.
23. Koshi R., Panicker A. M. A Study on Satisfaction Level of Jan Aushadhi Stores. 2020;7(5):776-787.
24. Amira B., Alyaa R., Ashraf W., Labiba El. K., Sally G. Community pharmacist’s perceptions, awareness and practices regarding counterfeit medicines: a cross-sectional survey in Alexandria, Egypt. EMHJ. 2020;26(5):556-564.
25. Priscilla A. G. Fundamentals of Survey Research Methodology. MITRE PRODUCT. Division: Department. 2005:800- 804.
26. Anthony M. A., Cecilia W. U. et. al., Jeff G. O., Leanna J. S., Leila K., Richard G. E., Wendy W. A Survey of Complementary and Alternative Medicine (CAM) Awareness among Neurosurgeons in Washington State. The Journal of Alternative and Complementary Medicine. 2009;15(5):551–555.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The International Journal of Drug Regulatory affairs require a formal written transfer of copyright from the author(s) for each article published. We therefore ask you to complete and return this form, retaining a copy for your records. Your cooperation is essential and appreciated. Any delay will result in a delay in publication.
I/we have read and agree with the terms and conditions stated Page 2 of this agreement and I/we hereby confirm the transfer of all copyrights in and relating to the above-named manuscript, in all forms and media, now or hereafter known, to the International Journal of Drug Regulatory affairs, effective from the date stated below. I/we acknowledge that the IJDRA is relying on this agreement in publishing the above-named manuscript. However, this agreement will be null and void if the manuscript is not published in the IJDRA.
Download link for COPYRIGHT FORM